Efficacy and tolerability of the dorzolamide 2%/timolol 0.5% combination (COSOPT) versus 0.005% (XALATAN) in the treatment of ocular hypertension or glaucoma: results from two randomized clinical trials.

Source:http://linkedlifedata.com/resource/pubmed/id/14982045

Download in:

View as

General Info

PMID
14982045